HCC oncogenesis is associated with strong upregulation of insulin growth factor 2 (IGF-II); this molecule, and not IGF-I, appears to be the oncogenic IGF-IR ligand in HCC [9]. This evidence concerns the gene IGF1 and hepatocellular carcinoma.